Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach

5,6-Dimethylxanthenone 4-acetic acid (DMXAA), also known as ASA404 and vadimezan, is a potent tumor blood vessel-disrupting agent and cytokine inducer used alone or in combination with other cytotoxic agents for the treatment of non-small cell lung cancer (NSCLC) and other cancers. However, the late...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Shu-Ting, Zhou, Zhi-Wei, He, Zhi-Xu, Zhang, Xueji, Yang, Tianxin, Yang, Yin-Xue, Wang, Dong, Qiu, Jia-Xuan, Zhou, Shu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338781/
https://www.ncbi.nlm.nih.gov/pubmed/25733813
http://dx.doi.org/10.2147/DDDT.S76021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338781/
https://www.ncbi.nlm.nih.gov/pubmed/25733813
http://dx.doi.org/10.2147/DDDT.S76021

Ejemplares similares